Neoplasia/BPH

	Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC. Cancer Med Ohba K, Oki M, Matsuda T, Miyata H, Kikuchi H, Inoue T, Shin T, Sekine Y, Narita S, Naito S, Tsuchiya N, Naito H, Sugimoto M, Numakura K, Kobayashi S, Ueda K, Igawa T, Mitsunari K, Matsuo T, Imamura R. PMID: 42745451 [PubMed - indexed for MEDLINE]
	Diagnostic performance of AI-powered prostate MRI against biopsy ground truth: quasi-continuous risk scoring versus fixed PI-RADS thresholds. Cancer Imaging Bayerl N, Appel J, Schmidt M, Cavallaro A, Grimm R, von Busch H, Wullich B, Hartmann A, Schlicht M, Uder M, May MS, Ellmann S. PMID: 42745323 [PubMed - indexed for MEDLINE]
	Machine learning and multi-omics clustering to map cellular rewiring and immune evasion in ccRCC. Hum Genomics Wang Z, Wang Y, Zhang J, Zhang Y, Xv S, Zhang L, Wang F, Xin D. PMID: 42745293 [PubMed - indexed for MEDLINE]
	Implementation of Systematic Fourth-Arm Traction and Articulating-Needle Drivers in Senhance Robotic Radical Prostatectomy: Initial Experience. Int J Urol Sekiguchi Z, Sasaki M, Matsumura K, Sato Y, Tomokiyo S, Nakazawa R, Kikuchi E. PMID: 42744745 [PubMed - indexed for MEDLINE]
	The Value of Bayesian Statistics in Prostate Cancer Research: A Clinician-Oriented Review. Clin Genitourin Cancer Yajima S, Yoshida S, Arita Y, Sato H, Hirakawa A, Masuda H, Fujii Y. PMID: 42744731 [PubMed - as supplied by publisher]
	Evaluating Caffeine Intake and Reduction in Patients with Lower Urinary Tract Symptoms (LUTS). Eur Urol Focus Okonji I, Garthwaite M, Drake M. PMID: 42744719 [PubMed - as supplied by publisher]
	Risk-dependent Benefit of Adjuvant Pembrolizumab in High-risk Clear Cell Renal Cell Carcinoma: A Multi-institutional Study. Eur Urol Oncol Shapiro DD, Roadman DF, Master VA, Peyton CC, McIntosh AG, Manley BJ, Spiess PE, Lotan P, Patil D, Dehghanmanshadi A, Amason R, Bouvette MJ, Blittschau B, Yim KH, Abreu N, Jayakumar V, Allen GO, Sexton WJ, Abel EJ. PMID: 42744717 [PubMed - as supplied by publisher]
	Radiation Therapy for Bladder Cancer: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol Ballas LK, Solanki AA, Baumann BC, Dirix P, Hassanzadeh C, Zaorsky NG, Apolo AB, Choudhury A, Chung PW, Holzbeierlein JM, Joshi M, Kim MM, Lee CT, Moroney W, Ritch CR, Saeed H, Upadhyay R, van der Heijden AG, Bradfield L, Helms AR, Efstathiou JA. PMID: 42744092 [PubMed - as supplied by publisher]
	Urological Content Accuracy as an Unmeasured Dimension in Generative AI Chatbot Communication About Sexual Health After Prostate Cancer. JMIR Cancer Isler B, Bayraktar AM. PMID: 42743405 [PubMed - in process]
	Authors' Reply: Urological Content Accuracy as an Unmeasured Dimension in Generative AI Chatbot Communication About Sexual Health After Prostate Cancer. JMIR Cancer Christiansen M, Eriksson H, Fagerström L. PMID: 42743403 [PubMed - in process]
	Effect of demographic characteristics on the outcome of prostate cancer salvage radiotherapy: Analysis from a randomized controlled trial. Cancer Lawal IO, Jani AB, Goyal S, Abiodun-Ojo O, Dhere V, Bell S, Patel P, Hershatter B, Chaudhary K, Mushtaq A, Shelton J, Hanasoge S, Sebastian N, Patel SA, Halkar R, Master VA, Carlos RC, Schuster DM. PMID: 42743317 [PubMed - indexed for MEDLINE]
	Recent studies explore the evolving use of radiation in patients with solid tumors: Radiotherapy may benefit select patients with kidney cancer, but more trials are still needed to determine its role in relation to standard treatments. Cancer Lawrence L. PMID: 42743134 [PubMed - in process]
	Efficacy and safety of thulium fiber laser versus conventional holmium:YAG laser in anatomical endoscopic enucleation of the prostate: a systematic review and pairwise meta-analysis. World J Urol Valdez-Gil OE, Espinoza-Gonzalez E, Zoller-Coronado LA, Zazueta-Estrada JA, Corrales-O JI, Santa Cruz-Venegas J, Rivera-Gastelum JL. PMID: 42742780 [PubMed - indexed for MEDLINE]
	Commentary on "PSA density for clinically significant prostate cancer detection: a retrospective cohort study on the influence of age and prostate volume". World J Urol Khan T, Ahmad R, Anwar R. PMID: 42742766 [PubMed - in process]
	Tri-modal PSMA PET/CT-MRI-US fusion biopsy for clinically significant prostate cancer: a prospective paired diagnostic study. Eur J Nucl Med Mol Imaging Huang C, Jin L, Sun Y, Wu M, Zhang X, Xu X, He X, Qiu F, Wang X, Guo L, Huang R, Li J, Deng S, Lin Y, Wei X, Zhang B, Huang Y. PMID: 42742683 [PubMed - as supplied by publisher]
	Transabdominal lumbar approach (TALA) versus retroperitoneal approach for robot-assisted renal surgery: a prospective randomised controlled trial. World J Urol Bieri U, Heining F, Javadov A, Lork M, Maletzki P, Adank JP, Hefermehl L. PMID: 42742659 [PubMed - indexed for MEDLINE]
	DNA damage repair gene defects combined predict the efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: a retrospective cohort study. Front Genet Qin K, Hu G, Song E. PMID: 42741774 [PubMed]
	Multidisciplinary expert consensus on treatment intensification in metastatic androgen pathway modulation-sensitive prostate cancer: a case-based RAND/UCLA analysis. Drugs Context Borque-Fernando Á, Alonso-Gordoa T, Juan-Fita MJ, Lopez Campos F, Pérez-Fentes DA, Vilaseca A, Moretones Agut C, Usán P, Maroto Rey P. PMID: 42741748 [PubMed]
	Interpretable machine-learning risk stratification at the time of diagnosis for 3-year mortality in de novo metastatic prostate cancer: development and temporal validation in SEER. Front Oncol Wang X, Yao G, Liu H, Ding W. PMID: 42741211 [PubMed]
	ADC-based radiomics for risk stratification in prostate cancer: a clinical decision support study. Front Oncol Zhang K, Zhang J, Yuan Y, Chen Z, Du Y, Liu H. PMID: 42741094 [PubMed]

Articles 1 - 20 / 191284

Page 1 of 9565



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy